255 related articles for article (PubMed ID: 23040068)
1. Cullin-3 regulates vascular smooth muscle function and arterial blood pressure via PPARγ and RhoA/Rho-kinase.
Pelham CJ; Ketsawatsomkron P; Groh S; Grobe JL; de Lange WJ; Ibeawuchi SR; Keen HL; Weatherford ET; Faraci FM; Sigmund CD
Cell Metab; 2012 Oct; 16(4):462-72. PubMed ID: 23040068
[TBL] [Abstract][Full Text] [Related]
2. RhoBTB1 protects against hypertension and arterial stiffness by restraining phosphodiesterase 5 activity.
Mukohda M; Fang S; Wu J; Agbor LN; Nair AR; Ibeawuchi SC; Hu C; Liu X; Lu KT; Guo DF; Davis DR; Keen HL; Quelle FW; Sigmund CD
J Clin Invest; 2019 Mar; 129(6):2318-2332. PubMed ID: 30896450
[TBL] [Abstract][Full Text] [Related]
3. Cullin-3 mutation causes arterial stiffness and hypertension through a vascular smooth muscle mechanism.
Agbor LN; Ibeawuchi SC; Hu C; Wu J; Davis DR; Keen HL; Quelle FW; Sigmund CD
JCI Insight; 2016 Nov; 1(19):e91015. PubMed ID: 27882355
[TBL] [Abstract][Full Text] [Related]
4. Dysfunction of Cullin 3 RING E3 ubiquitin ligase causes vasoconstriction and increased sodium reabsorption in diabetes.
Zhang Y; Guo Q; Jiang G; Zhang C
Arch Biochem Biophys; 2021 Oct; 710():109000. PubMed ID: 34343486
[TBL] [Abstract][Full Text] [Related]
5. The 2023 Walter B. Cannon Award Lecture: Mechanisms Regulating Vascular Function and Blood Pressure by the PPARγ-RhoBTB1-CUL3 Pathway.
Sigmund CD
Function (Oxf); 2024; 5(1):zqad071. PubMed ID: 38196837
[TBL] [Abstract][Full Text] [Related]
6. PPARγ regulates resistance vessel tone through a mechanism involving RGS5-mediated control of protein kinase C and BKCa channel activity.
Ketsawatsomkron P; Lorca RA; Keen HL; Weatherford ET; Liu X; Pelham CJ; Grobe JL; Faraci FM; England SK; Sigmund CD
Circ Res; 2012 Nov; 111(11):1446-58. PubMed ID: 22962432
[TBL] [Abstract][Full Text] [Related]
7. Aryl hydrocarbon receptor (AhR) regulates adipocyte differentiation by assembling CRL4B ubiquitin ligase to target PPARγ for proteasomal degradation.
Dou H; Duan Y; Zhang X; Yu Q; Di Q; Song Y; Li P; Gong Y
J Biol Chem; 2019 Nov; 294(48):18504-18515. PubMed ID: 31653699
[TBL] [Abstract][Full Text] [Related]
8. Dominant negative PPARγ promotes atherosclerosis, vascular dysfunction, and hypertension through distinct effects in endothelium and vascular muscle.
Pelham CJ; Keen HL; Lentz SR; Sigmund CD
Am J Physiol Regul Integr Comp Physiol; 2013 May; 304(9):R690-701. PubMed ID: 23447133
[TBL] [Abstract][Full Text] [Related]
9. The Lbc Rho guanine nucleotide exchange factor α-catulin axis functions in serotonin-induced vascular smooth muscle cell mitogenesis and RhoA/ROCK activation.
Bear MD; Li M; Liu Y; Giel-Moloney MA; Fanburg BL; Toksoz D
J Biol Chem; 2010 Oct; 285(43):32919-32926. PubMed ID: 20696764
[TBL] [Abstract][Full Text] [Related]
10. Protective Role for Tissue Inhibitor of Metalloproteinase-4, a Novel Peroxisome Proliferator-Activated Receptor-γ Target Gene, in Smooth Muscle in Deoxycorticosterone Acetate-Salt Hypertension.
Ketsawatsomkron P; Keen HL; Davis DR; Lu KT; Stump M; De Silva TM; Hilzendeger AM; Grobe JL; Faraci FM; Sigmund CD
Hypertension; 2016 Jan; 67(1):214-22. PubMed ID: 26597823
[TBL] [Abstract][Full Text] [Related]
11. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
[TBL] [Abstract][Full Text] [Related]
12. Salicylates dilate blood vessels through inhibiting PYK2-mediated RhoA/Rho-kinase activation.
Ying Z; Giachini FR; Tostes RC; Webb RC
Cardiovasc Res; 2009 Jul; 83(1):155-62. PubMed ID: 19276129
[TBL] [Abstract][Full Text] [Related]
13. PPARγ and RhoBTB1 in hypertension.
Fang S; Sigmund CD
Curr Opin Nephrol Hypertens; 2020 Mar; 29(2):161-170. PubMed ID: 31789920
[TBL] [Abstract][Full Text] [Related]
14. Activation of cold-sensing transient receptor potential melastatin subtype 8 antagonizes vasoconstriction and hypertension through attenuating RhoA/Rho kinase pathway.
Sun J; Yang T; Wang P; Ma S; Zhu Z; Pu Y; Li L; Zhao Y; Xiong S; Liu D; Zhu Z
Hypertension; 2014 Jun; 63(6):1354-63. PubMed ID: 24637663
[TBL] [Abstract][Full Text] [Related]
15. In Vitro and In Vivo Approaches to Assess Rho Kinase Activity.
Sauzeau V; Loirand G
Methods Mol Biol; 2017; 1527():213-218. PubMed ID: 28116719
[TBL] [Abstract][Full Text] [Related]
16. Genetic interference with peroxisome proliferator-activated receptor γ in smooth muscle enhances myogenic tone in the cerebrovasculature via A Rho kinase-dependent mechanism.
De Silva TM; Ketsawatsomkron P; Pelham C; Sigmund CD; Faraci FM
Hypertension; 2015 Feb; 65(2):345-51. PubMed ID: 25385762
[TBL] [Abstract][Full Text] [Related]
17. Smooth Muscle Peroxisome Proliferator-Activated Receptor γ Plays a Critical Role in Formation and Rupture of Cerebral Aneurysms in Mice In Vivo.
Hasan DM; Starke RM; Gu H; Wilson K; Chu Y; Chalouhi N; Heistad DD; Faraci FM; Sigmund CD
Hypertension; 2015 Jul; 66(1):211-20. PubMed ID: 25916724
[TBL] [Abstract][Full Text] [Related]
18. Role of calcium-independent phospholipase A2beta in high glucose-induced activation of RhoA, Rho kinase, and CPI-17 in cultured vascular smooth muscle cells and vascular smooth muscle hypercontractility in diabetic animals.
Xie Z; Gong MC; Su W; Xie D; Turk J; Guo Z
J Biol Chem; 2010 Mar; 285(12):8628-38. PubMed ID: 20086008
[TBL] [Abstract][Full Text] [Related]
19. Bcr kinase activation by angiotensin II inhibits peroxisome-proliferator-activated receptor gamma transcriptional activity in vascular smooth muscle cells.
Alexis JD; Wang N; Che W; Lerner-Marmarosh N; Sahni A; Korshunov VA; Zou Y; Ding B; Yan C; Berk BC; Abe J
Circ Res; 2009 Jan; 104(1):69-78. PubMed ID: 19023129
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol prevents AngII-induced hypertension via AMPK activation and RhoA/ROCK suppression in mice.
Cao X; Luo T; Luo X; Tang Z
Hypertens Res; 2014 Sep; 37(9):803-10. PubMed ID: 24965170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
